Affiliation:
1. Military Medical Academy named after S.M. Kirov
Abstract
The article discusses the potential opportunities for impact of antidiabetic drugs from the group of glucagon-like peptide-1 (GLP- 1) receptor agonists on the risks of development and progression of cardiovascular complications in patients with type 2 diabetes mellitus (T2DM) and their possible role in increasing the patients’ expectancy and quality of life. The existing differences between the drugs of this class should be taken into account in using personalized approach to therapy, developing and introducing new guidelines for specialized medical care for patients with type 2 diabetes into clinical practice. The article presented data on the efficacy and safety of the use of GLP-1 receptor agonists and discusses data on the possible mechanisms of non-glycemic effects underlying their cardio and nephroprotection. The features of pharmacological characteristics affecting the clinical efficacy and development of side effects are considered. The article also provides data from randomized clinical trials of various GLP-1 receptor agonists that demonstrate the positive effect of drugs of this class on cardiovascular and nephrological outcomes in patients with type 2 diabetes.
Reference31 articles.
1. Dedov I.I., Shestakova M.V., Vikulova O.K. et al. Diabetes mellitus in Russian Federation: prevalence, morbidity, mortality, parameters of glycaemic control and structure of glucose lowering therapy according to the Federal Diabetes Register, status 2017. Diabetes mellitus. 2018;21(3): 144-159. (In Russ.) doi: 10.14341/DM9686.
2. Shlyakhto Е.V., Shestakova M.V. Cardiovascular death risk reduction in type 2 diabetes patients with confirmed cardiovascular diseases. Russian Journal of Cardiology. 2018;(9):58-64. (In Russ.) doi: 10.15829/1560-4071-2018-9-58-64.
3. Htay T., Soe K., Lopez-Perez A., Doan A.H., Romagosa M.A., Aung K. Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes. Current Cardiology Reports. 2019;21(6):45. doi: 10.1007/s11886-019-1133-9.
4. Nikonova L.V., Doroshkevich I.P. Physiological effects of incretins in type 2 diabetes. Zhurnal Grodnenskogo gosudarstvennogo meditsinskogo universiteta = Journal of the Grodno State Medical University. 2013;(1):18-21. (In Russ.) Available at: http://elib.grsmu.by/handle/files/4037.
5. Moore B., Edie E., Abram J. On the treatment of diabetes mellitus by acid extract of duodenal mucosa membrane. Biochem J. 1906;1(1):28–38. doi: 10.1042/bj0010028.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献